Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 04 - 13 tags : Collaboration save search
Waters and Genovis Collaborate to Develop Efficient Workflows for Biopharmaceutical Characterization
Published: 2021-04-13 (Crawled : 13:00) - biospace.com/
WAT | $310.25 -0.97% 0.0% 530K
|
Health Technology
|
| O: 0.05%
H: 0.35%
C: 0.23%
biopharma collaboration
BridgeBio Pharma, Inc. and GlycoNet Initiate Collaboration to Discover Potential Treatments for Genetic Diseases through Glycomics Research
Published: 2021-04-13 (Crawled : 12:00) - globenewswire.com
BBIO | $25.02 -1.73% -1.76% 1.5M
|
Health Technology
|
| O: 0.43%
H: 2.42%
C: 0.76%
disease treatment genetic potential collaboration research
BridgeBio Pharma, Inc. and Oregon Health & Science University Establish Collaboration to Translate Pioneering Research into Therapies for Genetically Driven Diseases
Published: 2021-04-13 (Crawled : 12:00) - globenewswire.com
BBIO | $25.02 -1.73% -1.76% 1.5M
|
Health Technology
|
| O: 0.43%
H: 2.42%
C: 0.76%
disease genetic collaboration research therapy
BridgeBio Pharma, Inc. and Roswell Park Establish Collaboration to Translate Pioneering Research into Therapies for Genetically Driven Cancers
Published: 2021-04-13 (Crawled : 12:00) - globenewswire.com
BBIO | $25.02 -1.73% -1.76% 1.5M
|
Health Technology
|
| O: 0.43%
H: 2.42%
C: 0.76%
genetic collaboration cancer research therapy pharma
BridgeBio Pharma, Inc. and The Lundquist Institute Collaborate to Advance Treatments for Genetically Driven Conditions and Cancers
Published: 2021-04-13 (Crawled : 12:00) - biospace.com/
BBIO | $25.02 -1.73% -1.76% 1.5M
|
Health Technology
|
| O: 0.43%
H: 2.42%
C: 0.76%
treatment genetic cancer collaboration pharma
BridgeBio Pharma and the University of California, San Diego Announce Collaboration to Advance Treatments for Genetically Driven Conditions
Published: 2021-04-13 (Crawled : 12:00) - biospace.com/
BBIO | $25.02 -1.73% -1.76% 1.5M
|
Health Technology
|
| O: 0.43%
H: 2.42%
C: 0.76%
treatment genetic collaboration announces collaboration pharma
BridgeBio Pharma, Inc. and UC Davis Establish Collaboration to Transform Research into Potential Therapies for Genetically Driven Diseases
Published: 2021-04-13 (Crawled : 12:00) - biospace.com/
BBIO | $25.02 -1.73% -1.76% 1.5M
|
Health Technology
|
| O: 0.43%
H: 2.42%
C: 0.76%
disease genetic potential collaboration research therapy
Evotec Launches 'BeLAB2122', Translating Academic Innovation from Leading German Life Science Region in Collaboration with Bristol Myers Squibb
Published: 2021-04-13 (Crawled : 08:00) - biospace.com/
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: 0.35%
H: 1.32%
C: 1.07%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.66%
H: 0.86%
C: 0.48%
collaboration life science germany
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.